GlassScriptPhysician profile
Amanda C A Malone
NPI 1831974351
$1,439.11
in general payments reported to CMS, 2019-2025
12 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $44.34 · 2024: $1,254 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $775 · Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $774.60 |
| Food and Beverage | $664.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $967.07 | 2024 | 3m Skin and Nasal Antiseptic, Prevena, Spoton |
| Atricure, INC. | $140.66 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Novo Nordisk INC | $63.09 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Molnlycke Health Care US, LLC | $60.38 | 2024 | Exufiber Ag+, Mepilex Border Post-Op, Mepilex Border Sacrum |
| Abbvie INC. | $43.21 | 2023-2024 | |
| Coloplast Corp | $33.81 | 2024 | |
| Next Science LLC | $30.93 | 2024 | Surgx, Blastx, Xperience |
| Hydrofera LLC | $30.33 | 2024 | Hydrofera Blue |
| Convatec INC. | $26.94 | 2024 | |
| Smith+Nephew, INC. | $15.33 | 2024 | Collagenase Santyl |
| Mimedx Group, INC. | $14.41 | 2024 | |
| Kci USA, INC. | $12.95 | 2023 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.